Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Hyperammonemia due to valproic acid in the psychiatric setting.

Carr RB, Shrewsbury K.

Am J Psychiatry. 2007 Jul;164(7):1020-7. Review. No abstract available.

PMID:
17606652
2.

Valproate-associated hyperammonemic encephalopathy.

Wadzinski J, Franks R, Roane D, Bayard M.

J Am Board Fam Med. 2007 Sep-Oct;20(5):499-502. Review.

3.

Treatment guidelines for valproate in bipolar and schizoaffective disorders.

McElroy SL, Keck PE Jr.

Can J Psychiatry. 1993 Apr;38(3 Suppl 2):S62-6. Review.

PMID:
8500081
4.

Valproate in psychiatric disorders: literature review and clinical guidelines.

McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI.

J Clin Psychiatry. 1989 Mar;50 Suppl:23-9. Review.

PMID:
2494155
5.

Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy.

Mock CM, Schwetschenau KH.

Am J Health Syst Pharm. 2012 Jan 1;69(1):35-9. doi: 10.2146/ajhp110049. Review.

PMID:
22180549
6.

[Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].

Fassi G, Igoa A, Liste OA.

Vertex. 2008 Nov-Dec;19(82):371-7. Review. Spanish.

PMID:
19424520
7.

U.S. experience with valproate in manic depressive illness: a multicenter trial.

Brown R.

J Clin Psychiatry. 1989 Mar;50 Suppl:13-6. Review.

PMID:
2494153
8.

Evidence for a potential protective effect of carnitine-pantothenic acid co-treatment on valproic acid-induced hepatotoxicity.

Felker D, Lynn A, Wang S, Johnson DE.

Expert Rev Clin Pharmacol. 2014 Mar;7(2):211-8. doi: 10.1586/17512433.2014.871202. Epub 2014 Jan 22. Review.

PMID:
24450420
9.

Mixed episodes with psychotic features.

Chou JC.

CNS Spectr. 2009 Nov;14(11 Suppl 11):6-8; discussion 12-4. Review. No abstract available.

PMID:
20173694
10.

Valproate-induced hyperammonemia in mental retardation: a case report and review of the literature.

Khoo CL, Naik S, Lua R, Chai SB, Liew A, Sim K.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Apr 16;34(3):561-2. doi: 10.1016/j.pnpbp.2010.02.017. Epub 2010 Feb 23. Review. No abstract available.

PMID:
20184937
11.

A putative relationship between valproic acid and polycystic ovarian syndrome: implications for treatment of women with seizure and bipolar disorders.

Joffe H, Hall JE, Cohen LS, Taylor AE, Baldessarini RJ.

Harv Rev Psychiatry. 2003 Mar-Apr;11(2):99-108. Review. No abstract available.

PMID:
12868510
12.

Adverse drug reactions induced by valproic acid.

Nanau RM, Neuman MG.

Clin Biochem. 2013 Oct;46(15):1323-38. doi: 10.1016/j.clinbiochem.2013.06.012. Epub 2013 Jun 20. Review.

PMID:
23792104
13.

[A case of valproate-associated hyperammonemia with chronic hepatitis C].

Fukushima M, Kotoh K, Enjoji M, Nakamuta M, Nawata H, Aishima S.

Nihon Shokakibyo Gakkai Zasshi. 2005 Jan;102(1):42-7. Review. Japanese. No abstract available.

PMID:
15682815
14.

[Anticonvulsants treatment of psychiatric disorder in elderly patients].

Bidzan L.

Przegl Lek. 2006;63(7):583-7. Review. Polish.

PMID:
17203814
15.

[Valproic acid derivatives: toxicity and adverse effects].

Kłosiewicz L, Puzyński S.

Psychiatr Pol. 1987 Jan-Feb;21(1):57-61. Review. Polish. No abstract available.

PMID:
3112824

Supplemental Content

Support Center